Copyright
©The Author(s) 2023.
World J Gastroenterol. Dec 14, 2023; 29(46): 6060-6075
Published online Dec 14, 2023. doi: 10.3748/wjg.v29.i46.6060
Published online Dec 14, 2023. doi: 10.3748/wjg.v29.i46.6060
Figure 6 Circ563 promoting hepatocellular carcinoma tumor growth in vivo.
Mouse xenografts were generated to verify the role of circ563 in vivo. Hepatocellular carcinoma cells stably transfected with miR-148a-3p overexpression, metal-regulatory transcription factor-1 knockdown, or control vectors were implanted into the subcutaneous tumors of mice. The xenografts were treated with exosomes after four weeks. A-C: Accelerated growth of circ563-overexpressing Hep3B-derived xenografts is shown with increased tumor volume and weight compared with the control group. Both miR-148a-3p overexpression and metal-regulatory transcription factor-1 (MTF-1) depletion partially reversed the increase in tumor volume and weight; D and E: MTF-1 staining reveals a similar trend with cell growth. aP < 0.05, bP < 0.01, cP < 0.001. exo-circ563: Exosomal circ563; HCC: Hepatocellular carcinoma; MSC: Mesenchymal stem cell; Exo: Exosome; MTF-1: Metal-regulatory transcription factor-1.
- Citation: Lyu ZZ, Li M, Yang MY, Han MH, Yang Z. Exosome-mediated transfer of circRNA563 promoting hepatocellular carcinoma by targeting the microRNA148a-3p/metal-regulatory transcription factor-1 pathway. World J Gastroenterol 2023; 29(46): 6060-6075
- URL: https://www.wjgnet.com/1007-9327/full/v29/i46/6060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i46.6060